AbbVie Confirms Guidance of Greater Than $15 Billion in Combined Risk-Adjusted Sales for Rinvoq and Skyrizi in 2025 Pharmaceutical Investing
Komo Plant Based Foods Now Distributed in Ontario and Quebec Through BRR Logistics, a Unilever Master Distributor Company News
BioAtla Announces Clinical Collaboration with Bristol Myers Squibb to Study Mecbotamab Vedotin and Ozuriftamab Vedotin in Combination with Opdivo® for Treatment of Solid Tumors Pharmaceutical Investing
AMGEN AND BIOLABS LA AT THE LUNDQUIST INSTITUTE ANNOUNCE THAT KARMA BIOTECHNOLOGIES WILL RECEIVE THE SECOND AMGEN GOLDEN TICKET Market News
Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in First-Line Metastatic Non-Small Cell Lung Cancer Pharmaceutical Investing
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies Pharmaceutical Investing
Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan's 40th Annual Healthcare Conference Pharmaceutical Investing
EUROPEAN COMMISSION APPROVES LUMYKRAS® FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER Market News
AbbVie Submits Applications for Upadacitinib in Non-Radiographic Axial Spondyloarthritis to U.S. Food and Drug Administration and European Medicines Agency Pharmaceutical Investing
Komo Plant-Based Foods Begins United States Expansion with Appointment of U.S. Sales Agent Company News
